Yersinia enterocolitica: pathogenesis, virulence and antimicrobial resistance.

Fluoroquinolones or third generation cephalosporins, the best therapeutic options, are warranted to treat enterocolitis in compromised hosts and in patients with septicemia or invasive infection, in which the mortality can be as high as 50%.